Resultado tras el tratamientoquirúrgico de tumores de células gigantes
DOI:
https://doi.org/10.31053/1853.0605.v73.n4.12479Keywords:
tumor de células gigantes, tratamiento quirúrgico.Abstract
Resumen: Introducción: El tumor de células gigantes se presenta en adultos jóvenes, y su capacidad metastásica obliga a realizar un tratamiento quirúrgico, aunque su tasa de recurrencias hace que no haya consenso respecto a su manejo terapéutico. Material y métodos: 23 pacientes fueron intervenidos en el periodo de 1996 a 2012 en el hospital Miguel Servet, realizándose un seguimiento medio de 8,9 años. Resultados: el resultado funcional fue satisfactorio en todos los casos, pudiendo reanudar su actividad física habitual. Se detectaron 6 recurrencias, que fueron tratadas quirúrgicamente, mostrando los pacientes una recuperación total. Un paciente falleció a causa de metástasis pulmonares. Conclusión: El tratamiento quirúrgico es el más indicado en tumores de células gigantes, habiendo demostrado buenos resultados tanto en el tratamiento del tumor primario como en el de las recidivas.
Downloads
References
1.-Liede A1, Bach BA2, Stryker S1, Hernandez RK3, Sobocki P4, Bennett B5, Wong SS5. Regional variation and challenges in estimating the incidence of giant cell tumor of bone. J Bone Joint Surg Am. 2014 Dec 3;96(23):1999-2007.
2.- Jiang N1, Qin CH, Tan CX, Wen SF, Ma YF, Dong F, Diao XC, Zhang P, Yu B. A retrospective analysis of 140 patients with giant cell tumor in the extremity: a multicenter study based on four hospitals in South China. Cancer Epidemiol. 2013 Jun;37(3):294-9.
3.- Niu X, Xu H, Inwards CY, Li Y, Ding Y, Letson GD, Bui MM1Primary Bone Tumors: Epidemiologic Comparison of 9200 Patients Treated at Beijing Ji Shui Tan Hospital, Beijing, China, With 10?165 Patients at Mayo Clinic, Rochester, Minnesota.. Arch Pathol Lab Med. 2015 Sep;139(9):1149-55.
4.-. Zhang Z1, Xu J, Yao Y, Chu S, Cheng H, Chen D, Zhong P. Giant cell tumors of the skull: a series of 18 cases and review of the literature.J Neurooncol. 2013 Dec;115(3):437-44.
5.- Pereira HM1, Marchiori E, Severo A.J. Magnetic resonance imaging aspects of giant-cell tumours of bone. Med Imaging Radiat Oncol. 2014 Dec;58(6):674-8.
6.- Chan CM1, Adler Z2, Reith JD1, Gibbs CP. Risk factors for pulmonary metastases from giant cell tumor of bone. JrJ Bone Joint Surg Am. 2015 Mar 4;97(5):420-8.
7.- Cheng DD1, Hu T, Zhang HZ, Huang J, Yang QC.. Factors Affecting the Recurrence of Giant Cell Tumor of Bone After Surgery: A Clinicopathological Study of 80 Cases from a Single Center. Cell Physiol Biochem 2015;36(5):1961-70.
8.-Bergovec M, Petkovi? M, Smerdelj M, Seiwerth S, Brki? L, Robert K, Orli? D. Giant cell tumor of bone: results and treatment complications. Acta Med Croatica. 2014 Dec;68(4-5):405-10.
9.- Raskin KA1, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJJ. Giant cell tumor of bone. Am Acad Orthop Surg. 2013 Feb;21(2):118-26.
10.- Wysocki RW1, Soni E, Virkus WW, Scarborough MT, Leurgans SE, Gitelis S. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome? Clin Orthop Relat Res. 2015 Feb;473(2):706-15.
11.- Kundu ZS1, Gupta V, Sangwan SS, Rana P. Curettage of benign bone tumors and tumor like lesions: A retrospective analysis. Indian J Orthop. 2013 May;47(3):295-301.
12.- Chakarun CJ1, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GR Jr. Giant cell tumor of bone: review, mimics, and new developments in treatment. Radiographics. 2013 Jan-Feb;33(1):197-211.
13.-. Rajani R1, Schaefer L2, Scarborough MT3, Gibbs CP3 .Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment.. J Foot Ankle Surg. 2014 Oct 28.
14.- Loquercio G1, DI Costanzo G2, Fazioli F3, Gallo M3, DE Chiara A4, Iervolino V2, Azzaro R2, Petruzziello A2, Mattiello A2, Cacciapuoti C2. Autologous Platelet Gel Improves Bone Reconstruction of Large Defects in Patients with Bone Giant Cell Tumors. In Vivo. 2015 09-10;29(5):533-540.
15.-.Gouin F1, Dumaine V; French Sarcoma and Bone Tumor Study Groups GSF-GETO. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups). Orthop Traumatol Surg Res. 2013 Oct;99(6 Suppl):S313-8.
16.- Zhang S1, Xu MT, Wang XQ, Wang JJ. Functional outcome of en bloc excision and custom prosthetic replacement for giant cell tumor of the distal radius. J Orthop Sci. 2015 Sep 2.
17.- Hara H1, Akisue T2, Kawamoto T3, Onishi Y2, Fujioka H4, Nishida K5, Kuroda R6, Kurosaka M7, Akisue T8. Reconstruction of the Midfoot Using a Free Vascularized Fibular Graft After En Bloc Excision for Giant Cell Tumor of the Tarsal Bones: A Case Report. J Foot Ankle Surg. 2015 Jul 24. pii: S1067-2516(15)00183-0.
18.- AlSulaimani SA1, Turcotte RE; Canadian Orthopaedic Oncology Society (CANOOS) collaborators. Iterative curettage is associated with local control in giant cell tumors involving the distal tibia. Clin Orthop Relat Res. 2013 Aug;471(8):2668-74.
19.- Ma Y1, Xu W, Yin H, Huang Q, Liu T, Yang X, Wei H, Xiao J. Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review. Eur Spine J. 2015 Aug;24(8):1754-60. doi: 10.1007/s00586-015-3834-0. Epub 2015 May 6.
20.- Shi W1, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, Gibbs CP Jr, Mendenhall WM, Zlotecki RA. Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol. 2013 Oct;36(5):505-8. doi: 10.1097/COC.0b013e3182568fb6.
21.- Skubitz KM1. .Giant cell tumor of bone: current treatment options. Curr Treat Options Oncol. 2014 Sep;15(3):507-18.19.- Singh AS1, Chawla NS2, Chawla SP2. Giant-cell tumor of bone: treatment options and role of denosumab. Biologics. 2015 Jul 14;9:69-74.
22.- Singh AS1, Chawla NS2, Chawla SP2. Giant-cell tumor of bone: treatment options and role of denosumab. Biologics. 2015 Jul 14;9:69-74.
23.- Vaishya R1, Agarwal AK1, Vijay V2.'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab. Cureus. 2015 Jul 30;7(7):e291.
24.- Brodowicz T1, Hemetsberger M2, Windhager R3. Denosumab for the treatment of giant cell tumor of the bone. Future Oncol. 2015 Jul;11(13):1881-94.
25.- Lim SY1, Rastalsky N2, Choy E3, Bolster MB2. Tibial stress reaction presenting as bilateral shin pain in a man taking denosumab for giant cell tumor of the bone. Bone. 2015 Jun 25;81:31-35.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The generation of derivative works is allowed as long as it is not done for commercial purposes. The original work may not be used for commercial purposes.
How to Cite
